Form 8-K - Current report:
SEC Accession No. 0001367644-25-000204
Filing Date
2025-11-12
Accepted
2025-11-12 16:02:01
Documents
15
Period of Report
2025-11-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ebs-20251107.htm   iXBRL 8-K 29390
2 EX-99.1 a11122025retirementofdrsul.htm EX-99.1 5391
7 image2.jpg GRAPHIC 7489
  Complete submission text file 0001367644-25-000204.txt   195621

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebs-20251107.xsd EX-101.SCH 2059
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ebs-20251107_def.xml EX-101.DEF 15289
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebs-20251107_lab.xml EX-101.LAB 26963
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebs-20251107_pre.xml EX-101.PRE 15991
17 EXTRACTED XBRL INSTANCE DOCUMENT ebs-20251107_htm.xml XML 2722
Mailing Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879
Business Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 251472458
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)